Purification and N-terminal sequence of a serine proteinase-like protein (BMK-CBP) from the venom of the Chinese scorpion (Buthus martensii Karsch)
Introduction
Animal venoms are rich source of protein and peptide toxins, which can reach over 90% of the dry weight of the snake venom (Mebs, 1969). After injection, these proteins or peptides could target to different receptors on cells or molecules and induce various kinds of physiological changes. These include blood coagulation disorder (Kornalik, 1991), cytotoxic effect (Dufton and Hider, 1991), blockage of neuro-muscle transmission (Endo and Tamiya, 1991) and ion-channel blockage (Harvey and Anderson, 1991), etc. Many of these venom proteins or peptides have been isolated and well characterized. The high specificity and strong potency made them the good choice as the targeting molecules of drug delivering and the model for the drug design (Lewis and Garcia, 2003, Blumenthal and Seibert, 2003, Armishaw and Alewood, 2005).
Anticancer therapy is one of the major applications for the using of venom proteins and peptides. Some isolated proteins or peptides specifically bind to the cancer cell membrane and affect the cancer cell migration and proliferation. Based on their mechanisms, few families of venom proteins and peptides have been identified: [1] ion-channel toxins from scorpion, which affect the cancer cell physiology through blockage of the specific ion-channel (Jäger et al., 2004); [2] ligand of specific target on the membrane of cancer cell, such as chlorotoxin from scorpion venom (DeBin et al., 1993, Deshane et al., 2003), which binds to the metalloproteinase on gliomas and kill the cancer cells (Nabors, 2004, Mamelak and Jacoby, 2007); and [3] disintegrins or disintegrin-containing proteins from snake venoms, which affect the cancer cell through binding to integrin on cell surface (McLane et al., 2004).
To find the new proteins or peptides which could bind to the membrane receptor of cancer cell, we screen several snake and scorpion venom from Asia–Pacific region. In this communication, we report the purification, characterization and N-terminal sequencing of a serine proteinase-like protein from the venom of the Buthus martensii Karsch, which binds to the cancer cell membrane.
Section snippets
Materials
Superdex 75 (Hiload 16/60) and Sephasil C8 columns were from GE Healthcare Life Sciences, while UNO Q1 column was from Bio-Rad (USA). Chinese red scorpion (B. martensii Karsch) venom was bought from the scorpion farm of China and other snake venoms were purchased from the Venom Supplier (Australia). The chromogenic substrates of proteinase were bought from Chromogenix (Molndal, Sweden). All other chemicals were analytic scale.
Gel filtration of B. martensii Karsch venom
B. martensii Karsch venom (100 mg) was dissolved in 1 ml of 50 mM NH4HCO3
Screening of cell binding ability of snake and scorpion venoms
To identify the venom components, which could bind to cancer cell, we used breast cancer cell line MCF-7 as the host. Several snake venoms (including Elapid and Viperidae families) and scorpion venom from Asia–Pacific region were screened. As shown in Fig. 1, significant changes were observed for the venom of Agkistrodon halys, Russell's viper and B. martensii Karsch. Since the venoms of A. halys and Russell's viper are rich sources of disintegrin and disintegrin-containing proteins, these cell
Discussion
In this communication, we report the screening of cancer cell binding ability of several snake and scorpion venoms. In case of B. martensii Karsch venom, the venom was fractionated into 10 peaks by gel filtration: [1] high molecular proteins (including peaks 1–4, ≥19 kDa) and [2] small peptides (including peaks 5–10, 3–8 kDa). The small peptide fractions of scorpion venom are rich source of ion-channel toxins, which could bind to different channels on cell membrane and affect their function (see
Acknowledgement
The work was supported by grant R-398-000-030-305 from A*STAR SERC (Singapore).
References (37)
- et al.
Enzymes with gelatinolytic activity can be found in Tityus bahiensis and Tityus serrulatus venoms
Toxicon
(2002) - et al.
Purification, characterization, and amino acid sequence determination of acanthins, potent inhibitors of platelet aggregation from Acanthophis antarcticus (common death adder) venom
Arch. Biochem. Biophys.
(1998) - et al.
Phospholipin, a novel heterodimeric phospholipase A2 from Pandinus imperator scorpion venom
FEBS Lett.
(1999) - et al.
Plasminogen activators, tissue degradation, and cancer
Adv. Cancer Res.
(1985) - et al.
Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2
J. Biol. Chem.
(2003) - et al.
Characterization of three fibrinogenolytic enzymes from Chinese green tree viper (Trimeresurus stejnegeri) venom
Toxicon
(1998) - et al.
An overview of toxins and genes from the venom of the Asian scorpion Buthus martensi Karsch
Toxicon
(2002) - et al.
Molecular identification of a bevy of serine proteinases in Manduca sexta hemolymph
Insect Biochem. Mol Biol.
(2005) - et al.
Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin
J. Biol. Chem.
(2000) - et al.
Purification and properties of hyaluronidase from Palamneus gravimanus (Indian black scorpion) venom
Toxicon
(2006)
Selective recognition of alpha (2) beta (1) integrin by jararhagin, a metalloproteinase/disintegrin from Bothrops jararaca venom
Thromb. Res.
Current views on scorpion toxins specific for K+-channels
Toxicon
Pineapple cysteine endopeptidases
Methods Enzymol.
Effects of Pallas' viper (Agkistrodon halys Pallas) venom on blood coagulation and characterization of a prothrombin activator
Toxicon
The reprolysin jararhagin, a snake venom metalloproteinase, functions as a fibrillar collagen agonist involved in fibroblast cell adhesion and signaling
J. Biol. Chem.
ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK)
Cancer Res.
Conotoxins as research tools and drug leads
Curr. Protein Pept. Sci.
Voltage-gated sodium channel toxins: poisons, probes, and future promise
Cell Biochem. Biophys.
Cited by (32)
Identification of an antiviral component from the venom of the scorpion Liocheles australasiae using transcriptomic and mass spectrometric analyses
2021, ToxiconCitation Excerpt :In scorpion venom, enzymes have not been recognized as major bioactive components. However, recent progress in venom gland transcriptome analysis revealed that there are various enzymes, such as phospholipase, metalloprotease, serine protease, and hyaluronidase, in the venom (Bordon et al., 2015; Carmo et al., 2014; Gao, R. et al., 2008; Krayem and Gargouri, 2020). In this study, we identified three transcripts (LaPLA2-1, LaPLA2-2, and LaPLA2-3) coding for phospholipase A2, and eight transcripts (LaSP1, LaSP2, LaSP3, LaSP4, LaSP5, LaSP6, LaSP7, and LaSP8) coding for serine protease (Table S2).
Venom as therapeutic weapon to combat dreadful diseases of 21<sup>st</sup> century: A systematic review on cancer, TB, and HIV/AIDS
2018, Microbial PathogenesisCitation Excerpt :BMK-CBP is a serine proteinase-like protein which is extracted from Chinese red scorpion venom (Buthus martensii Karsch). It binds with MCF-7 cell line, and revealed the cell binding characteristic at varied concentrations [56]. BmHYA1, a hyaluronidase isolated from B. martensi converted hyaluronic acid into smaller oligosaccharides, and caused the modulation of CD44 expression and cell surface markers in breast cancer cell line [57].
Native and recombinant phospholipases A<inf>2</inf> of Scorpio maurus venom glands impair angiogenesis by targeting integrins α5β1 and αvβ3
2018, International Journal of Biological MacromoleculesIntegrin-mediated human glioblastoma cells adhesion, migration and invasion by native and recombinant phospholipases of Scorpio maurus venom glands
2018, Archives of Biochemistry and Biophysics